The company also reported an “imminent” submission of its latest, longest-lasting continuous glucose monitoring (CGM) technology.
Shares of SENS fell 3.5% to 69¢ apiece after the market closed today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the day down 0.6%.
Get the full story at our sister site, Drug Delivery Business News.